Welcome to the DZKF portal for advanced training
NOW ON-LINE: click here for access to the information clip about this advanced training portal: Watch information clip...
NEW & FREE OF CHARGE: Post your publications e.g. press releases, publications on the subject of indication, GCP/methodology, investigator and many more. For more information click here...
SPECIAL OFFER: ENDORSING RESEARCH! Get the printed DZKF Journal free of charge for one full year: You do not have a subbscription yet? Register with us now and you will receive the DZKF Journal for one year free of charge! For more information please click here...
| Eisenmenger-Syndrom: Diagnose und Therapie |  |
| Wenn bei angeborenen Herzfehlern ein so ausgeprägter primärer Links-Rechts-Shunt vorliegt, dass sich eine pulmonale Widerstandserhöhung mit konsekutiver Shuntumkehr und deutlicher Zyanose entwickelt, spricht man vom eisenmenger-Syndrom. |
| more |
 | 6.2 Clinical safety: post-approval, 11. - 15. June 2012, Basel - Switzerland |
| Clinical safety: post-approval
Key questions to be tackled by the course
- Modalities of detection, analysis and validation of drug-induced adverse events(pharmacovigilance)
- Pharmacoepidemiology as a tool for the identification and study of drug-induced adverse events
- Diagnosis and management acute drug poisonings
- Riskminimization activities in the post-marketing phase
- Medication errors
- Assessment of drug abuse and misuse
- Occupational safety in workers exposed to active drug ingredients
- Post-approval safety commitments |
| more |
|
